Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Ependymoma × Radiotherapy × Clear all

Phase

Phase 2 3 Phase EARLY_PHASE1 2 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 56 Carcinoma, Non-Small-Cell Lung 42 Lung Neoplasms 33 Head and Neck Neoplasms 26 Pancreatic Neoplasms 25 Gliosarcoma 25 Squamous Cell Carcinoma of Head and Neck 24 Rectal Neoplasms 21 Central Nervous System Neoplasms 21 Brain Neoplasms 20 Astrocytoma 16 Neoplasms 15 Breast Neoplasms 15 Uterine Cervical Neoplasms 14 Prostatic Neoplasms 13 Glioma 13 Sarcoma 12 Carcinoma, Squamous Cell 11 Esophageal Neoplasms 10 Lymphoma, Follicular 9 Leukemia 9 Melanoma 8 Lymphoma 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Lymphoma, Large B-Cell, Diffuse 7 Small Cell Lung Carcinoma 6 Neoplasm Metastasis 6 Myelodysplastic Syndromes 6 Lymphoma, Non-Hodgkin 6

Interventions

Temozolomide 11 Filgrastim 5 Cyclophosphamide 4 Thiotepa 3 Etoposide 3 Carmustine 3 Carboplatin 3 Automobiles 3 sargramostim 2 Radiation 2 Peripheral Blood Stem Cell Transplantation 2 ONC206 2 Nivolumab 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Immunohistochemistry 2 Imiquimod 2 Imatinib Mesylate 2 Granulocyte Colony-Stimulating Factor 2 Azacitidine 2 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 2 1-methyltryptophan 2 vitespin 1 veliparib 1 vatalanib 1 trametinib 1 thymoglobulin 1 temsirolimus 1 sonidegib 1 ribociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04732065 2026-03-17

PNOC023

University of California, San Francisco

Phase 1 Recruiting

Ependymoma, Glioblastoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡